EP2552920
Ný NK-3 viðtakasértæk blokkaefnasambönd, lyfjafræðileg efnasamsetning og aðferðir til að beita á raskanir fyrir tilverknað NK-3 viðtaka
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
4.4.2011EP published:
15.3.2017EP application number:
11711922.2
EP translation filed:
26.5.2017Grant published:
15.6.2017EPO information:
European Patent Register
Max expiry date:
3.4.2031Expiry date:
3.4.2026Next due date:
30.4.2026
Title:
NOVEL NK-3 RECEPTOR SELECTIVE ANTAGONIST COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN NK-3 RECEPTORS MEDIATED DISORDERS
Timeline
Today
4.4.2011EP application
15.3.2017EP Publication
26.5.2017Translation submitted
15.6.2017Registration published
3.4.2026Expires
Owner
Name:
OGEDA SAAddress:
Rue Adrienne Bolland 47, 6041, Charleroi, BE
Inventor
Name:
HOVEYDA, HamidAddress:
Bruxelles, BE
Name:
ROY, Marie-OdileAddress:
Paris, FR
Name:
FRASER, Graeme LovatAddress:
Bousval, BE
Name:
DUTHEUIL, GuillaumeAddress:
Vedrin, BE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
379028 PDate:
1.9.2010Country:
US
Number:
10305343Date:
2.4.2010Country:
EP
Classification
Categories:
C07D 487/04, A61K 31/495, A61P 25/00, A61P 29/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 10.5.2017
Expires: 3.4.2018
Payer: G. H. Sigurgeirsson
Number: 8
Paid: 21.3.2018
Expires: 3.4.2019
Payer: G. H. Sigurgeirsson
Number: 9
Paid: 10.4.2019
Expires: 3.4.2020
Payer: G. H. Sigurgeirsson
Number: 10
Paid: 14.4.2020
Expires: 3.4.2021
Payer: G.H. Sigurgeirsson ehf.
Number: 11
Paid: 18.3.2021
Expires: 3.4.2022
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 21.3.2022
Expires: 3.4.2023
Payer: Patice ehf.
Number: 13
Paid: 21.3.2023
Expires: 3.4.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 19.3.2024
Expires: 3.4.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 2.4.2025
Expires: 3.4.2026
Payer: Árnason Faktor ehf.